Pharmacy Faculty Research

Title

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Dose of CBR-2092 in Healthy Volunteers (CBR-2092-001)

Role

Lead Pharmacist

Location

Dallas, TX

Share

COinS